Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loh

Showing results (341-350 of 479) with videos related to

Pageof 48
Sort By:
Kidney Diseases (Basel, Switzerland)|September 14, 2020
The Value of Renal Biopsy in Non-Insulin-Dependent Diabetes Mellitus in Singapore over the Past Two DecadesKeng Thye Woo, Choong Meng Chan, Cynthia Lim, et al.
Nature|January 18, 2018
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemiaGannie Tzoneva, Chelsea L Dieck, Koichi Oshima, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Blood|January 5, 2023
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group reportNathan P Gossai, Meenakshi Devidas, Zhiguo Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.
Molecular Cancer Research : MCR|April 26, 2020
The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic LeukemiaJoanna Pierro, Jason Saliba, Sonali Narang, et al.
Leukemia|April 15, 2018
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemiaMelissa A Burns, Zi Wei Liao, Natsuko Yamagata, et al.
Blood|September 8, 2012
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemiaShannon L Maude, Sarah K Tasian, Tiffaney Vincent, et al.
Blood Advances|May 5, 2026
Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology GroupEtan Orgel, Luke D Maese, Meenakshi Devidas, et al.
Blood|November 22, 2015
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemiaSeth E Karol, Leonard A Mattano, Wenjian Yang, et al.
Pageof 48

Showing results (341-350 of 479) with videos related to

Sort By:
Pageof 48
Kidney Diseases (Basel, Switzerland)|September 14, 2020
The Value of Renal Biopsy in Non-Insulin-Dependent Diabetes Mellitus in Singapore over the Past Two DecadesKeng Thye Woo, Choong Meng Chan, Cynthia Lim, et al.
Nature|January 18, 2018
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemiaGannie Tzoneva, Chelsea L Dieck, Koichi Oshima, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Blood|January 5, 2023
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group reportNathan P Gossai, Meenakshi Devidas, Zhiguo Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.
Molecular Cancer Research : MCR|April 26, 2020
The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic LeukemiaJoanna Pierro, Jason Saliba, Sonali Narang, et al.
Leukemia|April 15, 2018
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemiaMelissa A Burns, Zi Wei Liao, Natsuko Yamagata, et al.
Blood|September 8, 2012
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemiaShannon L Maude, Sarah K Tasian, Tiffaney Vincent, et al.
Blood Advances|May 5, 2026
Toxicity from asparaginase during acute lymphoblastic leukemia induction: A report from the Children's Oncology GroupEtan Orgel, Luke D Maese, Meenakshi Devidas, et al.
Blood|November 22, 2015
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemiaSeth E Karol, Leonard A Mattano, Wenjian Yang, et al.
Pageof 48